Page
%P
-
Article
Open AccessPharmacological targeting of eIF4E in primary CLL lymphocytes
-
Chapter
DNA-PK in CLL Chemotherapy
DNA is the principal target of many conventional anticancer agents, and inhibition of DNA repair is one of the most promising strategies in novel cancer therapy. Many studies demonstrated that nonhomologous en...
-
Article
Open AccessKi 67 is a major, but not the sole determinant of Oncotype Dx recurrence score
Immunohistological assessment of Ki 67 expression is less expensive than Oncotype Dx, which is currently used to identify patients with lymph node-negative breast cancer, who will benefit from adjuvant chemoth...
